WO2002030950A3 - Haplotypes du gene fy - Google Patents

Haplotypes du gene fy Download PDF

Info

Publication number
WO2002030950A3
WO2002030950A3 PCT/US2001/042725 US0142725W WO0230950A3 WO 2002030950 A3 WO2002030950 A3 WO 2002030950A3 US 0142725 W US0142725 W US 0142725W WO 0230950 A3 WO0230950 A3 WO 0230950A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
haplotypes
disclosed
haplotyping
genotyping
Prior art date
Application number
PCT/US2001/042725
Other languages
English (en)
Other versions
WO2002030950A2 (fr
Inventor
Anne Chew
Julie Y Choi
Beena Koshy
Original Assignee
Genaissance Pharmaceuticals
Anne Chew
Julie Y Choi
Beena Koshy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Anne Chew, Julie Y Choi, Beena Koshy filed Critical Genaissance Pharmaceuticals
Priority to AU2002211920A priority Critical patent/AU2002211920A1/en
Publication of WO2002030950A2 publication Critical patent/WO2002030950A2/fr
Publication of WO2002030950A3 publication Critical patent/WO2002030950A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne de nouveaux variants génétiques du gène du système Duffy (FY). Elle concerne également divers génotypes, haplotypes, et paires d'haplotypes du gène FY existants dans la population générale des Etats-Unis. L'invention concerne en outre des compositions et des méthodes d'haplotypage et/ou de génotypage du gène FY chez un individu. Elle concerne enfin des polynucléotides définis par les haplotypes de l'invention.
PCT/US2001/042725 2000-10-13 2001-10-15 Haplotypes du gene fy WO2002030950A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002211920A AU2002211920A1 (en) 2000-10-13 2001-10-15 Haplotypes of the fy gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24027500P 2000-10-13 2000-10-13
US60/240,275 2000-10-13

Publications (2)

Publication Number Publication Date
WO2002030950A2 WO2002030950A2 (fr) 2002-04-18
WO2002030950A3 true WO2002030950A3 (fr) 2002-08-29

Family

ID=22905880

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/042725 WO2002030950A2 (fr) 2000-10-13 2001-10-15 Haplotypes du gene fy

Country Status (2)

Country Link
AU (1) AU2002211920A1 (fr)
WO (1) WO2002030950A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2897983A1 (fr) * 2004-02-06 2005-08-18 Canadian Blood Services Procede de determination simultane d'un groupe sanguin et de genotypes d'antigene plaquette sanguine

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHAUDHURI ET AL.: "Cloning of glycoprotein D cDNA, which encodes the major subunit of the duffy blood group system and the receptor for the plasmodium vivax malaria parasite", PROC. NATL. ACAD. SCI. USA, vol. 90, November 1993 (1993-11-01), pages 10793 - 10797, XP002941966 *
DATABASE GENBANK [online] 23 November 1999 (1999-11-23), BAGGULEY: "Human DNA sequence from clone 134P22 on chromosome 1q21.2-22", XP002950922, accession no. NCBI Database accession no. (AL035403) *
IWAMOTO ET AL.: "Genomic organization of the glycoprotein D gene duffy blood group Fya/Fyb alloantigen system is associated with a polymorphism at the 44-amino acid residue", BLOOD, vol. 85, no. 3, February 1995 (1995-02-01), pages 622 - 626, XP000974000 *
YAZDANBAKHSH ET AL.: "Molecular mechanisms that lead to reduced expression of duffy antigens", TRANSFUSION, vol. 40, March 2000 (2000-03-01), pages 310 - 320, XP002950923 *

Also Published As

Publication number Publication date
AU2002211920A1 (en) 2002-04-22
WO2002030950A2 (fr) 2002-04-18

Similar Documents

Publication Publication Date Title
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2002018414A3 (fr) Haplotypes du gène bf
WO2002030950A3 (fr) Haplotypes du gene fy
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2001079228A3 (fr) Haplotypes du gene f12
WO2002090512A3 (fr) Haplotypes du gene nnmt
WO2002010454A3 (fr) Haplotypes du gene alas2? ¿
WO2002012562A3 (fr) Haplotypes du gene pla2g1b
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2001094362A3 (fr) Haplotypes du gene acp2
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2002042320A3 (fr) Haplotypes du gene de glutathione reductase
WO2001092278A3 (fr) Haplotypes du gene rlbp1
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2002002580A3 (fr) Haplotypes du gene etfb
WO2002038586A3 (fr) Haplotypes du gene il6
WO2001092279A3 (fr) Haplotypes du gene aldh5
WO2002044201A3 (fr) Haplotypes du gene sah
WO2002055534A3 (fr) Haplotypes du gene f2rli
WO2002016399A3 (fr) Haplotypes du gene tacr1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP